LCM
CRBP icon

Laurion Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Laurion Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Buy
19,600
+1,000
+5% +$8.42K 0.01% 323
2025
Q4 		$151K Buy
+18,600
New +$230K 0.01% 288
2017
Q2 		– Sell
-4,100
Closed -$1.01M – 1659
2017
Q1 		$1.01M Buy
+4,100
New +$1.01M 0.01% 739

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Laurion Capital Management's CRBP Position: Q1 2026 in Review

Laurion Capital Management increased its Corbus Pharmaceuticals (CRBP) stake by 5.4% in Q1 2026, buying an estimated $8.42K and bringing the position to 19,600 shares worth $184K. The position accounts for 0.01% of the portfolio, ranked #323.

Laurion Capital Management first reported a position in CRBP in Q1 2017 and has held it in 3 quarters since. The position peaked at $1.01M in Q1 2017. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Laurion Capital Management held 19,600 shares of Corbus Pharmaceuticals worth $184K as of Q1 2026.
  • Laurion Capital Management bought 1,000 Corbus Pharmaceuticals shares in Q1 2026, an estimated $8.42K.
  • Corbus Pharmaceuticals made up 0.01% of Laurion Capital Management's portfolio in Q1 2026, its #323 holding.
  • Laurion Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2017 and has held it in 3 quarters since.
  • Laurion Capital Management's Corbus Pharmaceuticals position peaked at $1.01M in Q1 2017.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.